Skip to main content

Oncology Startups

Updated November 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 313 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
313
Total Funding
$947.8M
Avg Funding
$37.9M
Global Reach
8
countries

Top Cities for Oncology

Geleen
New York
Wilmington
Waltham
Medford
Halifax

Recently Funded Companies

Export
Geleen, The Netherlands

Temple Therapeutics creates and develops therapies for orthopedics, oncology, and endometriosis patients.

$325K raised
Dec 2023

Founder Contacts

41,000+ verified contacts

New York, United States

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

$14.4M raised
Dec 2023

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.

$102.0M raised
Dec 2023

Founder Contacts

41,000+ verified contacts

Waltham, United States

Mural Oncology is a protein engineering platform to reimagine cytokine-based immunotherapies for the treatment of cancer.

$275.0M raised
Nov 2023

Founder Contacts

41,000+ verified contacts

Medford, United States

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

$10.0M raised
Oct 2023

Founder Contacts

41,000+ verified contacts

Halifax, Canada

Adaptiiv specializes in medical device and software development that helps practitioners in cancer treatment operations.

$963K raised
Oct 2023

Founder Contacts

41,000+ verified contacts

Berkeley, United States

Actym Therapeutics is a biotech company that focuses on the discovery and development of novel immuno-oncology therapies to treat cancer.

$25.5M raised
Oct 2023

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

$5.0M raised
Oct 2023

Founder Contacts

41,000+ verified contacts

Paris, France

Epigene Labs designs genomics-driven drug for precision oncology.

$1.6M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Plymouth Meeting, United States

Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.

$5.0M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

$39.0M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Watertown, United States

Mariana Oncology is a biotechnology research industry.

$175.0M raised
Sep 2023

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Solid Therapeutics develops novel cancer therapeutics with dual performance targeting cancer cells and immune cells to treat solid tumors.

Sep 2023

Founder Contacts

41,000+ verified contacts

California City, United States

Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.

$52.5M raised
Aug 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

$20.0M raised
Aug 2023

Founder Contacts

41,000+ verified contacts

Berkeley, United States

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

$125.0M raised
Jul 2023

Founder Contacts

41,000+ verified contacts

Chicago, United States

Alnair Therapeutics is a preclinical stage precision oncology platform focusing on developing innovative approaches to treat difficult.

$1.0M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic engineering.

$4.1M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Leuven, Belgium

Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.

$1.9M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Monmouth Junction, United States

Elucida Oncology develops targeted C'Dot Drug Conjugates (CDCs) for patients with primary solid tumor and metastatic cancer.

$22.9M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Vysioneer is an oncology AI company that enables pharma and clinicians to find the right treatment for tumors.

$750K raised
Jun 2023

Founder Contacts

41,000+ verified contacts

New York, United States

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

$50.0M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Philadelphia, United States

We are the first HIPAA compliant platform that focuses on optimizing cancer treatment plans for patients in China locally, on a B2B model.

May 2023

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden

iCellate is a Swedish research and development company focused on cancer research and detection products.

$1.9M raised
May 2023

Founder Contacts

41,000+ verified contacts

Seattle, United States

OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.

$14.0M raised
May 2023

Founder Contacts

41,000+ verified contacts

Showing 201 to 225 of 313 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 313 oncology companies tracked in the VCBacked database.

Average Funding
$37.9M
Total Funding Tracked
$947.8M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.New York
2 companies$64.4M
2.Berkeley
2 companies$150.5M
3.Philadelphia
2 companies$5.0M
4.Cambridge
2 companies$20.8M
5.Geleen
1 companies$325K

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

313 Oncology Startups (2026) — Recently Funded — Page 9 | VCBacked